patent.fyi
Applications  /  US 2026/0356872
United States Patent Application Publication

US 2026/0356872 A1

Published
Nov 12, 2026
Filed
Apr 28, 2026
Earliest date on the face
Apr 28, 2025
Classification
C07H 5/06
First published here
Nov 20, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

No entries.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Reference solution for solubility testing

An analytical laboratory uses glucosamine orotate as a test material for a high-concentration aqueous solubility assay. A weighed excess of the salt is stirred with water in a sealed, temperature-controlled vial. After the dissolved concentration stabilizes and residual solid remains, a clarified sample is diluted by mass and assayed for glucosamine and orotate. The laboratory records the dissolved salt concentration together with the equilibration temperature.

Component substitution

Batch exchange with anion resin

A stirred vessel containing a strong-base anion exchange resin in the hydroxide form replaces the packed column. The vessel receives aqueous glucosamine hydrochloride, and the resin takes up chloride while releasing hydroxide that deprotonates glucosammonium. A screen retains the resin as the liquid transfers to a stirred suspension of orotic acid. The operator measures residual chloride before transfer and adds the liquid according to its measured glucosamine content.

Parameter or scale variation

Small batches with controlled feed

A 10 mL hydroxide-form anion exchange bed supplies a jacketed 100 mL stirred vessel containing 5 mmol of orotic acid suspended in 30 mL of water. The vessel operates at 25 °C, and a metering pump delivers the column effluent at 1 mL/min. The run delivers 5 mmol of glucosamine based on the measured effluent concentration. The vessel stirs for 15 minutes after dosing, and a sample is checked for residual solids and dissolved orotate.

Combination with existing systems

Salt isolation by vacuum drying

A vacuum tray dryer receives the aqueous glucosamine orotate solution after ion exchange and reaction with orotic acid. A particulate filter sits between the reaction vessel and the dryer feed container, and shallow trays hold the filtered solution. Reduced pressure removes water while a temperature sensor tracks the tray temperature. The isolated solid is checked for residual water and for its glucosamine-to-orotate molar ratio.

Orotic acid feed through a recirculation loop

A stirred tank holding an orotic acid suspension recirculates through a solids-handling pump and a static mixer with passages sized for the suspended particles. The glucosamine stream from the ion exchange column enters the recirculation line immediately upstream of the mixer. The mixer disperses the feed into the moving suspension, and the combined stream returns below the liquid surface. The tank continues to recirculate after dosing until samples taken at successive intervals show a stable dissolved orotate concentration.

Automated or data-driven variant

Sensor controlled effluent routing

A flow meter and a chloride-selective electrode monitor the effluent from a hydroxide-form ion exchange column. A controller switches a three-way valve from a collection vessel to the orotic acid reactor when chloride falls below a preset limit and flow reaches its setpoint. The controller returns the valve to the collection vessel when chloride exceeds the limit or the scheduled feed volume has entered the reactor. The controller logs chloride readings, cumulative flow, and valve position for each batch.

Cite aspatent.fyi, US 2026/0356872 A1, claim 1, first published 2026-11-20T08:11:50-05:00, https://patent.fyi/US20260356872/, SHA-256 778f349fc6d6c70f1adf2cf9b960545f020766f32dbd6a3101bf90f0587cd612
First published
Permanent addresshttps://patent.fyi/US20260356872/
Content fingerprint (SHA-256)778f349fc6d6c70f1adf2cf9b960545f020766f32dbd6a3101bf90f0587cd612
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi